Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP925924.RA-wVNDBwL7yxdXWYkeOCda21FVn6jZWJrJqHzqCXy_VM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP925924.RA-wVNDBwL7yxdXWYkeOCda21FVn6jZWJrJqHzqCXy_VM130_assertion type Assertion NP925924.RA-wVNDBwL7yxdXWYkeOCda21FVn6jZWJrJqHzqCXy_VM130_head.
- NP925924.RA-wVNDBwL7yxdXWYkeOCda21FVn6jZWJrJqHzqCXy_VM130_assertion description "[We reviewed the frequency and prognostic significance of FLT3 (fms-like tyrosine kinase receptor-3) and NPM (nucleophosmin) gene mutations and WT1 (Wilms' tumor) and BAALC (brain and acute leukemia, cytoplasmic) gene expression in 100 consecutive patients with intermediate and poor cytogenetic risk de novo acute myeloid leukemia (AML) receiving conventional anthracycline-AraC based therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP925924.RA-wVNDBwL7yxdXWYkeOCda21FVn6jZWJrJqHzqCXy_VM130_provenance.
- NP925924.RA-wVNDBwL7yxdXWYkeOCda21FVn6jZWJrJqHzqCXy_VM130_assertion evidence source_evidence_literature NP925924.RA-wVNDBwL7yxdXWYkeOCda21FVn6jZWJrJqHzqCXy_VM130_provenance.
- NP925924.RA-wVNDBwL7yxdXWYkeOCda21FVn6jZWJrJqHzqCXy_VM130_assertion SIO_000772 21942328 NP925924.RA-wVNDBwL7yxdXWYkeOCda21FVn6jZWJrJqHzqCXy_VM130_provenance.
- NP925924.RA-wVNDBwL7yxdXWYkeOCda21FVn6jZWJrJqHzqCXy_VM130_assertion wasDerivedFrom befree-2016 NP925924.RA-wVNDBwL7yxdXWYkeOCda21FVn6jZWJrJqHzqCXy_VM130_provenance.
- NP925924.RA-wVNDBwL7yxdXWYkeOCda21FVn6jZWJrJqHzqCXy_VM130_assertion wasGeneratedBy ECO_0000203 NP925924.RA-wVNDBwL7yxdXWYkeOCda21FVn6jZWJrJqHzqCXy_VM130_provenance.